Therefore, these results showed that promoting for lipolysis through inhibiting the p62-Nrf2-CES2 signaling axis and enhancing for β-oxidation through increasing p62-Nrf2-PPARα signaling axis are the mechanisms of bicyclol but not berberine to alleviate NAFLD. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.